Gadolinium-based contrast agents: update from Guerbet LLC on U.S. FDA requirements. Gadolinium-based contrast agents: update on MHLW decision in Japan. Employee director elected to Guerbet's Board of Directors. 조영제란 영상진단의학에 사용되는 약물입니다. 신원성 전신 섬유증(NSF)에 대한 정보입니다. At this year’s RSNA. Discover our integrated offers and see how our team fosters and improves innovation on patient management. Last update: 9.03.18.
http://guerbet.co.kr/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Saturday
LOAD TIME
2.2 seconds
16x16
32x32
PAGES IN
THIS WEBSITE
11
SSL
EXTERNAL LINKS
254
SITE IP
213.162.50.17
LOAD TIME
2.248 sec
SCORE
6.2
게르베코리아 | guerbet.co.kr Reviews
https://guerbet.co.kr
Gadolinium-based contrast agents: update from Guerbet LLC on U.S. FDA requirements. Gadolinium-based contrast agents: update on MHLW decision in Japan. Employee director elected to Guerbet's Board of Directors. 조영제란 영상진단의학에 사용되는 약물입니다. 신원성 전신 섬유증(NSF)에 대한 정보입니다. At this year’s RSNA. Discover our integrated offers and see how our team fosters and improves innovation on patient management. Last update: 9.03.18.
guerbet.co.kr
Information for Healthcare Professionals and other Stakeholders
http://guerbet.co.kr/news/news/news-detail/article2/information-4.html
Information for Healthcare Professionals and other Stakeholders. Updated Information about NSF. Stakeholders Updated Information about NSF. Last Update: April 2013). Last update: 17.12.14.
Sitemap
http://guerbet.co.kr/no_cache/footer/sitemap.html
Last update: 31.10.14.
Contrast media
http://guerbet.co.kr/contrast-media.html
게르베는 다양한 X-ray 및 MRI 조영제를 제공합니다. XENETIX (제네틱스300주사 , 제네틱스350주사 ). Hexabrix 는 이온성, 저삼투압 요오드 조영제입니다. 소아에서 성인에 이르기까지 넓은 범위의 환자에게 사용될 수 있습니다. 이온성, 고삼투압 요오드 조영제로서 주로 자궁난관 조영, 위장관 검사 등 비혈관조영에 사용됩니다. Meglumine Gadoterate (메글루민 가도테레이트). Dotarem 은 성인 및 소아를 대상으로 하는 모든 MRI에 사용될 수 있습니다. 무색의 바이알 또는 위아래가 막힌 유리관(pre-filled syringe, PFS) 형태로 제공됩니다. LIPIODOL Ultra-Fluid (리피오돌울트라액 ). Lipiodol Ultra-Fluid 는 양귀비 종자유에서 추출한 요오드화지방산의 에틸 에스테르로, 1901년 게르베에 의해 발견되었고 1926년에 최초의 X-ray 조영제로 사용되었습니다. 주로 림프관이나 침샘조영에 사용됩니다.
Credits
http://guerbet.co.kr/footer/credits.html
Guerbet Korea Ltd. (게르베 코리아). KPR ( http:/ www.kpr.co.kr. Consulting, ergonomics and design, functionnalities :. Open Bridge ( http:/ www.openbridge.com/. Guerbet Korea Ltd. (게르베 코리아). Open Bridge ( http:/ www.openbridge.com/. Guerbet Korea Ltd. (게르베 코리아). Last update: 17.12.14.
News detail
http://guerbet.co.kr/news/news/news-detail/article2/-e20ff996b6.html
게르베코리아 식목일 기념 나무 심기 행사 진행. Last update: 17.12.14.
TOTAL PAGES IN THIS WEBSITE
11
Orders
http://www.codali.be/orders.html
Nouvelles conditions générales de vente applicables au 1er juillet 2011. Consulter. Nieuwe algemene verkoopsvoorwaarden geldig vanaf 1 juli 2011. Klik hier. Click here to place your orders : orders.be(at)guerbet-group.com. Last update: 23.09.15.
医療関係の皆様
http://guerbet.jp/healthcare-professionals.html
ゲルべ ジャパン株式会社によるセミナー情報、関連する学会情報になります セミナー 講演会 学会情報。 Last update: 14.11.14.
Our Products
http://guerbet.cn/contrast-media.html
CT and Cath Lab contrast agents. Imaging Solutions and Services. Our products are intended to be administered to patients by health professionals. The information given below does not in any way aim to encourage their use by patients. The product indications of each of our products may vary from one country to another. For more information, please refer to the product information in force in your country. Guerbet offers a comprehensive range of medical imaging products for CT and Cath Lab. CT and Cath Lab.
Credits
http://www.codali.be/menu-bas-de-page/credits.html
Sa Guerbet n.v. Consulting, ergonomics and design, functionnalities :. Openbridge ( http:/ www.openbridge.fr/. Http:/ www.nurun.com/. Sa Guerbet n.v. Openbridge ( http:/ www.openbridge.fr/. Http:/ www.henandhay.com/. Last update: 5.08.11.
Guerbet Belgium
http://www.codali.be/index.php?id=guerbet-group
Guerbet completes acquisition of Mallinckrodt’s Contrast Media and Delivery Systems business (CMDS). Frost and Sullivan Applauds Guerbet's Novel, Syringe-free CT Contrast Injector, FlowSens. Fresh success for Guerbet at JFR 2015. A complete range for medical Imaging. ECR 2016: The New Guerbet is presenting its new global offers. Last update: 18.08.16.
News
http://www.codali.be/professional/news/news/article2/video-watc.html
Last update: 11.12.15.
Contrast media
http://www.codali.be/professional/contrast-media.html
Last update: 11.05.16.
Sitemap
http://www.codali.be/no_cache/menu-bas-de-page/site-map.html
What is a contrast agent? Notifier un effet secondaire / Een nevenwerking melden. Last update: 7.07.10.
News
http://www.codali.be/professional/news/news/article2/flowsensR-4.html
Last update: 11.12.15.
TOTAL LINKS TO THIS WEBSITE
254
Guerbet USA
90 years of passion. Gadolinium-based contrast agents: FDA Requirements December 2017 Guerbet LLC Update. FDA Approves Guerbet’s Dotarem (gadoterate meglumine) for Pediatric Patients Younger Than Two Years. Guerbet Statement Following Medical Imaging Drugs Advisory Committee September 8, 2017. Dotarem (gadoterate meglumine) Injection is approved in the US for intravenous use and is the first and only macrocyclic and ionic gadolinium-based contrast agent in USA. At this year’s RSNA.
Guerbet Asia Pacific
Gadolinium-based Contrast Agents: update on PRAC recommendations. Guerbet, a new global leader en route to the future. 2016 half-year results on track. 90 years of passion! Guerbet celebrated its 90-year anniversary and 20 years of presence at the RSNA Meeting. Asia Pacific area and Worldwide. Last update: 31.03.17.
Guerbet Belgium
Gadolinium-base Contrast Agents : update on PRAC recommendations. ECR 2017: Guerbet will be there! Explore 90 years of passion on guerbet90.com. A complete range for medical Imaging. At this year’s RSNA. Discover our integrated offers and see how our team fosters and improves innovation on patient management. Guerbet makes full use of its know-how and innovative capacity to meet the major public health challenges of the 21st century. Last update: 19.02.18.
Guerbet Asia Pacific
Guerbet announces its acquisition of Accurate Medical Therapeutics. Gadolinium-based contrast agents: update from Guerbet LLC on U.S. FDA requirements. Gadolinium-based contrast agents: update on MHLW decision in Japan. At this year’s RSNA. Discover our integrated offers and see how our team fosters and improves innovation on patient management. We Are: Discover Guerbet's new video. Asia Pacific area and Worldwide. Last update: 15.03.18.
게르베코리아
Gadolinium-based contrast agents: update from Guerbet LLC on U.S. FDA requirements. Gadolinium-based contrast agents: update on MHLW decision in Japan. Employee director elected to Guerbet's Board of Directors. 조영제란 영상진단의학에 사용되는 약물입니다. 신원성 전신 섬유증(NSF)에 대한 정보입니다. At this year’s RSNA. Discover our integrated offers and see how our team fosters and improves innovation on patient management. Last update: 9.03.18.
Guerbet United Kingdom
5th Guerbet Southern MRI Study Day. 2nd KCH Radiographer Cardiac Study Day. What is contrast media? What are its uses in modern medicine? Events and useful links. Further information on radiological events in the UK and worldwide. Some helpful links for professionals. Last update: 20.12.17.
Guerbet Group, Corporate website
2017 Annual Results: Satisfactory activity slightly exceeding the objectives. Guerbet teams will attend ECR 2018! Guerbet to present its integrated offerings including Contrast&Care , a new contrast media injection management solution, at 2018 European Congress of Radiology (ECR). We Are: Discover Guerbet's new video. Innovation at the heart of. Last update: 28.03.18.
Guerbet Brasil
90 anos de paixão. Matéria na Healtthcare Management: Guerbet: a gigante global em imagem médica. Conquistas e melhorias da Guerbet no Brasil são destaques no jornal Valor Econômico. Encontro de executivos da Guerbet com distribuidores. Ir para Arquivo -. A Guerbet concluiu a aquisição da unidade de negócio de Meios de Contraste e Sistemas de Injeção da Mallinckrodt (CMDS). Esta aquisição reúne as vantagens complementares de cada empresa para criar um novo líder global na imagiologia médica.
Guerbet Asia Pacific
Guerbet announces its acquisition of Accurate Medical Therapeutics. Gadolinium-based contrast agents: update from Guerbet LLC on U.S. FDA requirements. Gadolinium-based contrast agents: update on MHLW decision in Japan. At this year’s RSNA. Discover our integrated offers and see how our team fosters and improves innovation on patient management. We Are: Discover Guerbet's new video. Asia Pacific area and Worldwide. Last update: 15.03.18.
Guerbet Türkiye
Guerbet TNRD 27. Yıllık Toplantısında. Kontrast maddeler, tanısal görüntüleme amacıyla kullanılan ürünlerdir. Ürünlerimiz hakkında bilgi almak isterseniz lütfen tıklayınız. Uygulamaları gereği, ü. Rünlerimizle ilgili herhangi bir yan etki bildiriminde bulunmak için lütfen tıklayını z. De Guerbet Radyoloji çözümlerine genel bakış. Avrupa Farmakovijilans Risk Değerlendirme Komitesi Güncel Değerlendirme hk. Online Yayın talebi veya mesaj iletmek için tıklayınız. Güncelleme : 27.02.18.
